Cinryze Infusion Reverses Plasma Activation In Hereditary Angioedema
WASHINGTON DC - New data show that replacement therapy with Cinryze (C1 inhibitor-nf) infusion reverses all abnormalities of the plasma bradykinin-forming pathway and fibrinolysis that are responsible for the swelling attacks in patients with hereditary angioedema (HAE).
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment